About Erly Sign
Erly Sign is a company based in Nagpur (India) founded in 2019 by Deovrat Begde and Shubhendra Singh Thakur. Erly Sign has raised $2.17 million across 4 funding rounds from investors including LetsVenture, Ashish Kacholia and Laxmi investments FZCO. Erly Sign offers products and services including Erly Sign Kit, Nutritionist Consultation, and Doctor Consultation. Erly Sign operates in a competitive market with competitors including Viome Life Sciences, Vigilant Biosciences, Proteocyte, PeriRx and OralDNA, among others.
- Headquarter Nagpur, India
- Founders Deovrat Begde, Shubhendra Singh Thakur
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curo Biosciences Private Limited
- Date of Incorporation 14 Aug, 2019
- Jurisdiction Nagpur, Maharashtra, India
-
Annual Revenue
$3.99 K (USD)-83.63as on Mar 31, 2023
-
Net Profit
-$43.61 K (USD)-102.48as on Mar 31, 2023
-
EBITDA
-$30.4 K (USD)22.97as on Mar 31, 2023
-
Total Equity Funding
$2.17 M (USD)
in 4 rounds
-
Latest Funding Round
$1.86 M (USD), Seed
Jan 13, 2025
-
Investors
LetsVenture
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Erly Sign
Erly Sign offers a comprehensive portfolio of products and services, including Erly Sign Kit, Nutritionist Consultation, and Doctor Consultation.
Saliva-based test for early oral cancer detection and risk evaluation.
Free guidance on diet and lifestyle changes for moderate risk users.
Advice for high-risk individuals on further testing and management.
Funding Insights of Erly Sign
Erly Sign has successfully raised a total of $2.17M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.86 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Erly Sign
Erly Sign has secured backing from 7 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include LetsVenture, Ashish Kacholia and Laxmi investments FZCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early and growth stage tech startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Online platform that connects startup founders with accredited investors, enabling early-stage fundraising and investment opportunities for private market growth
|
Locked | Locked | Locked |
Investor details for Erly Sign
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Erly Sign
Investment portfolio details for Erly Sign
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Erly Sign
Detailed financials for Erly Sign
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Erly Sign Comparisons
Peer comparison for Erly Sign
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Erly Sign
Erly Sign operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Vigilant Biosciences, Proteocyte, PeriRx and OralDNA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Solutions for early oral cancer detection are developed and provided.
|
|
| Locked | Locked | Locked |
Diagnostic tests for predicting cancer development risks are provided.
|
|
| Locked | Locked | Locked |
Saliva-based tests for oral cancer risk stratification are developed.
|
|
| Locked | Locked | Locked |
Saliva-based tests for periodontal disease and infections are developed.
|
Detailed competitors of Erly Sign
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Erly Sign
Complete news archive for Erly Sign
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Erly Sign
Erly Sign was founded in 2019.
Erly Sign is headquartered in Nagpur, India. It is registered at Nagpur, Maharashtra, India.
Shubhendra Singh Thakur is the current CEO of Erly Sign. They have also founded this company.
Erly Sign is a funded company, having raised a total of $2.17M across 4 funding rounds to date.
Annual revenue of Erly Sign is $3.99K as on Mar 31, 2023.
A platform providing test kits for detecting oral cancer. The test kit helps in early detection of cancer using the saliva sample of users. Users can register and order the test kits for testing at home. The test results, reports, and consultations are provided for users after the test.
Erly Sign's top competitors include Viome Life Sciences, Vigilant Biosciences and Proteocyte.
Erly Sign offers Erly Sign Kit, Nutritionist Consultation, and Doctor Consultation.
Erly Sign has 7 investors. Key investors include LetsVenture, Ashish Kacholia, Laxmi investments FZCO, Rajesh Manthena, and Anthill Ventures.
The valuation of Erly Sign is $2.69M as of Jun 2023.